InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $172.000 4.42 (2.51%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17,998 PME signs A$40M - 7 year contract with Intermountain Health 14 Jan 2021 8:57AM $31.770 $172.280 risen by 442.27%
$17,998 CEO Interview Medstar deal and single vendor solution 17 Dec 2020 11:19AM $31.780 $172.280 risen by 442.10%
$17,998 PME signs A$18M - 5 year contract with MedStar Health 17 Dec 2020 9:51AM $31.120 $172.280 risen by 453.60%
$17,998 Updated Results of AGM - 2020 26 Nov 2020 4:25PM $29.680 $172.280 risen by 480.46%
$17,998 Results of AGM - 2020 25 Nov 2020 11:38AM $29.760 $172.280 risen by 478.90%
$17,998 AGM Presentation 2020 25 Nov 2020 10:00AM $31.130 $172.280 risen by 453.42%
$17,998 PME signs A$8.5M renewal deal with Zwanger-Pesiri 19 Nov 2020 11:09AM $31.070 $172.280 risen by 454.49%
$17,998 Amended UBS conference - Nov 2020 16 Nov 2020 12:12PM $32.590 $172.280 risen by 428.63%
$17,998 UBS Conference - Nov 2020 16 Nov 2020 10:39AM $32.590 $172.280 risen by 428.63%
$17,998 Amended AGM Notice of Annual General Meeting 27 Oct 2020 2:51PM $32.590 $172.280 risen by 428.63%
$17,998 Annual Report 2020 23 Oct 2020 9:10AM $34.120 $172.280 risen by 404.92%
$17,998 PME Annual General Meeting virtual online guide 23 Oct 2020 9:09AM $34.120 $172.280 risen by 404.92%
$17,998 Notice of Annual General Meeting 23 Oct 2020 9:08AM $34.120 $172.280 risen by 404.92%
$17,998 Annual General Meeting Proxy Form 23 Oct 2020 9:06AM $34.120 $172.280 risen by 404.92%
$17,998 PME signs A$10M deal with Ludwig-Maximilians University 15 Oct 2020 9:40AM $29.010 $172.280 risen by 493.86%
$17,998 Updated Appendix 4G & Corporate Governance Statement 24 Sep 2020 1:40PM $26.350 $172.280 risen by 553.81%
$17,998 Response to ASX Query 24 Sep 2020 1:33PM $26.350 $172.280 risen by 553.81%
$17,998 CEO Interview - NYU Langone Health deal 11 Sep 2020 11:44AM $25.050 $172.280 risen by 587.74%
$17,998 PME signs Research Collaboration with NYU Langone Health 11 Sep 2020 11:41AM $25.050 $172.280 risen by 587.74%
$17,998 PME signs A$25M deal with NYU Langone Health 11 Sep 2020 11:40AM $24.990 $172.280 risen by 589.40%
$17,998 Appendix 2A - Vesting of Performance Rights 31 Aug 2020 9:53AM $26.340 $172.280 risen by 554.06%
$17,998 Change of Director's Interest Notice - Deena Shiff 24 Aug 2020 8:56AM $26.120 $172.280 risen by 559.57%
$17,998 Proposed issue of Securities - PME 21 Aug 2020 1:12PM $25.780 $172.280 risen by 568.27%
$17,998 FY2020 Results Presentation 20 Aug 2020 10:34AM $24.020 $172.280 risen by 617.24%
$17,998 Interview with CEO - Full year results 20 Aug 2020 9:52AM $25.310 $172.280 risen by 580.68%

351 - 375 of 679 results

Page 15 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.